Stakeholders push for greater inclusion in FDA’s race and ethnicity data collection guidance
Regulatory NewsEmily Hayes
Biologics/ biosimilars/ vaccinesClinical TrialsMedical DevicesPharmaceuticalsUnited StatesRegulatory NewsEmily HayesBiologics/ biosimilars/ vaccinesClinical TrialsMedical DevicesPharmaceuticalsUnited States